Halozyme Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
/ 
Frequently asked questions
To buy Halozyme Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Halozyme Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Halozyme Therapeutics Inc. is HALO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Halozyme Therapeutics Inc. has its primary listing on NASDAQ. You can trade Halozyme Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Halozyme Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Halozyme Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Halozyme Therapeutics Inc..